September 15, 2025 a 01:00 pm
WST: Fundamental Ratio Analysis - West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. operates within the healthcare sector, focusing on containment and delivery systems for injectable drugs. The company's commitment to innovation positions it well in the competitive pharmaceutical packaging market. However, fluctuations in healthcare regulations could impact future performance.
Fundamental Rating
West Pharmaceutical Services, Inc. receives solid fundamental scores in various metrics with some room for improvement in valuation ratios.
| Category | Score | Visual |
|---|---|---|
| Discounted Cash Flow (DCF) | 4 | |
| Return On Equity (ROE) | 4 | |
| Return On Assets (ROA) | 5 | |
| Debt To Equity | 3 | |
| Price To Earnings (P/E) | 1 | |
| Price To Book (P/B) | 1 |
Historical Rating
The historical perspective shows a stable performance in most metrics, though recent scores indicate specific areas needing attention.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-12 | 3 | 4 | 4 | 5 | 3 | 1 | 1 |
| Previous | 0 | 4 | 4 | 5 | 3 | 1 | 1 |
Analyst Price Targets
Analysts suggest consistent price targets, reflecting market confidence despite the current economic landscape.
| High | Low | Median | Consensus |
|---|---|---|---|
| $245 | $245 | $245 | $245 |
Analyst Sentiment
The sentiment among analysts is predominantly positive, though some divergence in opinion remains.
| Recommendation | Count | Visual |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 10 | |
| Hold | 2 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
West Pharmaceutical Services, Inc. demonstrates strong potential in the healthcare sector, driven by innovation in packaging technologies. While fundamental scores are solid, valuation ratios indicate the market's premium pricing. The analyst consensus supports a 'Buy' recommendation, underscoring the potential for growth. However, market risks and regulatory changes pose challenges that must be navigated carefully.